BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21816462)

  • 1. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles.
    Yoshitomi T; Hirayama A; Nagasaki Y
    Biomaterials; 2011 Nov; 32(31):8021-8. PubMed ID: 21816462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
    Yoshitomi T; Nagasaki Y
    Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice.
    Vong LB; Tomita T; Yoshitomi T; Matsui H; Nagasaki Y
    Gastroenterology; 2012 Oct; 143(4):1027-36.e3. PubMed ID: 22771506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox nanoparticle therapeutics to cancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect.
    Yoshitomi T; Ozaki Y; Thangavel S; Nagasaki Y
    J Control Release; 2013 Nov; 172(1):137-143. PubMed ID: 23958903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive radical-containing-nanoparticle (RNP) for the L-band-EPR imaging of low pH circumstances.
    Yoshitomi T; Suzuki R; Mamiya T; Matsui H; Hirayama A; Nagasaki Y
    Bioconjug Chem; 2009 Sep; 20(9):1792-8. PubMed ID: 19685867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel neuroprotection using antioxidant nanoparticles in a mouse model of head trauma.
    Takahashi T; Marushima A; Nagasaki Y; Hirayama A; Muroi A; Puentes S; Mujagic A; Ishikawa E; Matsumura A
    J Trauma Acute Care Surg; 2020 May; 88(5):677-685. PubMed ID: 32039974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant.
    Mei T; Kim A; Vong LB; Marushima A; Puentes S; Matsumaru Y; Matsumura A; Nagasaki Y
    Biomaterials; 2019 Sep; 215():119209. PubMed ID: 31181394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
    Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
    J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurovascular Unit Protection From Cerebral Ischemia-Reperfusion Injury by Radical-Containing Nanoparticles in Mice.
    Hosoo H; Marushima A; Nagasaki Y; Hirayama A; Ito H; Puentes S; Mujagic A; Tsurushima H; Tsuruta W; Suzuki K; Matsui H; Matsumaru Y; Yamamoto T; Matsumura A
    Stroke; 2017 Aug; 48(8):2238-2247. PubMed ID: 28655813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroxyl radical-containing nanoparticles for novel nanomedicine against oxidative stress injury.
    Yoshitomi T; Nagasaki Y
    Nanomedicine (Lond); 2011 Apr; 6(3):509-18. PubMed ID: 21542688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects.
    Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
    Biomaterials; 2016 Aug; 99():109-23. PubMed ID: 27235996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Design of New Cancer Nanotherapeutics Which Controls Active Gaseous Molecules in Vivo].
    Nagasaki Y
    Yakugaku Zasshi; 2018; 138(7):911-918. PubMed ID: 29962468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term bioavailability of redox nanoparticles effectively reduces organ dysfunctions and death in whole-body irradiated mice.
    Feliciano CP; Tsuboi K; Suzuki K; Kimura H; Nagasaki Y
    Biomaterials; 2017 Jun; 129():68-82. PubMed ID: 28324866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer.
    Shashni B; Nagasaki Y
    Biomaterials; 2018 Sep; 178():48-62. PubMed ID: 29908344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroxide radicals and nanoparticles: a partnership for nanomedicine radical delivery.
    Nagasaki Y
    Ther Deliv; 2012 Feb; 3(2):165-79. PubMed ID: 22834195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Toxicity and Antioxidant Activity of Redox Nanoparticles in Zebrafish (Danio rerio) Embryos.
    Vong LB; Kobayashi M; Nagasaki Y
    Mol Pharm; 2016 Sep; 13(9):3091-7. PubMed ID: 27186993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer.
    Vong LB; Yoshitomi T; Matsui H; Nagasaki Y
    Biomaterials; 2015 Jul; 55():54-63. PubMed ID: 25934452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly synthesized radical-containing nanoparticles enhance neuroprotection after cerebral ischemia-reperfusion injury.
    Marushima A; Suzuki K; Nagasaki Y; Yoshitomi T; Toh K; Tsurushima H; Hirayama A; Matsumura A
    Neurosurgery; 2011 May; 68(5):1418-25; discussion 1425-6. PubMed ID: 21273921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.
    Sha S; Vong LB; Chonpathompikunlert P; Yoshitomi T; Matsui H; Nagasaki Y
    Biomaterials; 2013 Nov; 34(33):8393-400. PubMed ID: 23896000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia.
    Rak R; Chao DL; Pluta RM; Mitchell JB; Oldfield EH; Watson JC
    J Neurosurg; 2000 Apr; 92(4):646-51. PubMed ID: 10761655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.